Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06339034
PHASE1/PHASE2

Repurposing Lithium for Parkinson's Disease: a RCT

Sponsor: State University of New York at Buffalo

View on ClinicalTrials.gov

Summary

This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.

Official title: Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-07-03

Completion Date

2026-02

Last Updated

2025-07-08

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Lithium

5mg of elemental lithium/capsule

OTHER

Placebo

Cellulose-filled capsules

Locations (1)

UBMD Neurology

Williamsville, New York, United States